2026

CROI 2026: Islatravir PrEP didn’t protect against M184V mutation in macaque study

24 February 2026. Related: Conference reports, HIV prevention and transmission, Drug resistance.

CROI 2026: 11 mg dose selected for once-monthly alimatravir (MK-8527) for phase 3 PrEP studies

24 February 2026. Related: Conference reports, HIV prevention and transmission.

CROI 2026: Continued HIV protection from 2:1:1 PrEP dosing in gay and bisexual men in Paris

24 February 2026. Related: Conference reports, HIV prevention and transmission.

CROI 2026: Overview and research to watch out for

23 February 2026. Related: Conference reports.

CROI 2026: Introduction and main themes

21 February 2026. Related: Conference reports.

HPV and anal cancer in HIV+ gay men: new campaign in Manchester: anal HPV in gay men on PrEP

7 February 2026. Related: Journal scan, Coinfections and complications, Cancer and HIV.

US funding cuts set to drive 23 million excess deaths in the poorest countries by 2030

5 February 2026. Related: Journal scan, Treatment access.

Cobicistat (Tybost) discontinuation in UK by the end of 2026

29 January 2026. Related: Treatment alerts, Treatment access.

Do ATIs in HIV cure-related studies cause anxiety?

27 January 2026. Related: Journal scan, Cure-related research.

The Morning After: new podcast interviews UK community activists

25 January 2026. Related: Activism & advocacy, On the web.

Achieving greater HIV viral suppression and reducing stimulant use in San Francisco pilot programme

12 January 2026. Related: Journal scan, Coinfections and complications, Activism & advocacy.

Cancer and women living with HIV: results from D:A:D and RESPOND support including screening in routine HIV care

11 January 2026. Related: Journal scan, Women's health, Cancer and HIV.

Confirmed safety of kidney transplant when both recipient and donor are HIV positive

11 January 2026. Related: Journal scan, Coinfections and complications, Cancer and HIV, Hepatitis coinfection.

Neutralising antibodies wane two years after mpox infection or vaccination: protection persists

10 January 2026. Related: Journal scan, mpox.

Event-based PrEP dosing for women: a challenge to guidelines and an activist issue

5 January 2026. Related: Special reports, Guidelines, HIV prevention and transmission.